Abstract
Patients often develop nausea, vomiting and bloating after bone marrow transplantation (BMT). These symptoms may interfere with nutrition and the ability to take oral medications. Gastroparesis is a recognized cause of these symptoms in non-transplant patients but less is known about patients who undergo BMT. Between January 1996 and March 1997, a total of 151 patients underwent BMT. Eighteen patients (12%) developed persistent symptoms suggestive of gastroparesis (persistent nausea, vomiting or bloating). Scintigraphic gastric emptying studies were performed to assess for gastroparesis. Prokinetic agents were administered at the time of study. The records on these patients were compared with those of all other patients undergoing BMT during the same time period without these symptoms. Nine patients who demonstrated delayed gastric emptying were further evaluated with esophagastroduodenoscopy and biopsy. Biopsy samples were reviewed for evidence of graft-versus-host disease (GVHD). Fourteen of 18 patients demonstrated delayed gastric emptying and most responded to prokinetic agents given at the time of study. Age, conditioning regimen, cytomegalovirus antigenemia and acute GVHD did not appear to be associated with the development of gastroparesis. Allogeneic BMT recipients were at higher risk than autologous BMT patients (26% vs 0%, P < 0.0001). Of allogeneic BMT recipients, there was a nonsignificant trend of patients receiving tacrolimus to be less likely to experience gastroparesis than those receiving cyclosporine (27% vs 48%, P = 0.08). For the nine patients undergoing upper endoscopy, GVHD on gastric biopsy was an uncommon finding and was mild when present. Gastroparesis appears to be a common cause of nausea, vomiting and bloating following allogeneic BMT. This may occur less often with tacrolimus than cyclosporine because of the former agent's prokinetic properties. Patients usually respond to prokinetic drugs at the time of scintigraphy. GVHD and CMV infection do not appear to be major contributing factors. Bone Marrow Transplantation (2001) 28, 59–62.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Quigley EM . Gastric and small intestinal motility in health and disease Gastroenterol Clin N Am 1996 1: 113–145
Jaehoon JO, Kim CH . Gastroparesis after a presumed viral illness: clinical and laboratory features and natural history Mayo Clin Proc 1990 65: 636–642
Johnson DA, Winters C, Drane WE et al. Solid-phase gastric emptying in patients with Barrett's esophagus Dig Dis Sci 1986 31: 1217–1220
Fahey F, Zeissman HA, Collen M, Eggli D . Left anterior oblique projection and peak-to-scatter ratio for attenuation compensation of gastric emptying studies J Nucl Med 1989 30: 233–239
Domstad P, Kim EE, Coupal JJ et al. Biologic gastric emptying time in diabetic patients, using Tc-99m-labeled resin-oatmeal with and without metoclopramide J Nucl Med 1980 21: 1098–1100
Snover DC, Weisdorf SA, Vercellotis GM et al. An histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation Hum Path 1985 16: 387–392
Berkowitz N, Schulman L, McGregor C, Markowtiz D . Gastroparesis after lung transplantation. Potential role in postoperative respiratory complications Chest 1995 108: 1602–1607
Au J, Hawkins T, Venables C et al. Upper gastrointestinal dysmotility in heart–lung transplant recipients Ann Thorac Surg 1993 55: 94–97
Brand R, DiBaise J, Quigley EM et al. Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation Lancet 1998 352: 1985
Hecht JR, Lembo T, Chap L . Prolonged nausea and vomiting after high dose chemotherapy and autologous peripheral stem cell transplantation in the treatment of high risk breast carcinoma Cancer 1997 79: 1698–1702
Maes BD, Vanwalleghem J, Kuypers D et al. Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporin Transplantation 1999 68: 1482–1485
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eagle, D., Gian, V., Lauwers, G. et al. Gastroparesis following bone marrow transplantation. Bone Marrow Transplant 28, 59–62 (2001). https://doi.org/10.1038/sj.bmt.1703084
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703084
Keywords
This article is cited by
-
Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic stem cell transplantation
Bone Marrow Transplantation (2018)
-
Gastroparesis after living-donor lobar lung transplantation: report of five cases
Surgery Today (2015)
-
Accidental Overdose of Oral Cyclosporine in Haematopoietic Stem Cell Transplantation: A Case Report and Literature Review
Drug Safety - Case Reports (2015)
-
Clinical effect of individualized parenteral nutrition vs conventional method in patients undergoing autologous hematopoietic SCT
Bone Marrow Transplantation (2013)
-
Palliative care in BMT
Bone Marrow Transplantation (2009)